SCHEMBL6705407

SCHEMBL6705407

COc1cccc(OC)c1NC(=O)c1ccc(Oc2cc(C(C)(C)C)c(Br)cc2Br)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 4/20 0.46
S1PR2 O95136 2/20 0.46
S1PR3 Q99500 2/20 0.46
GAA P10253 2/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
KDM4E B2RXH2 3/20 0.41
S1PR1 P21453 1/20 0.41
S1PR5 Q9H228 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 4/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
MAPK10 P53779 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6673483 0.91 FPR1 (0.43) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL6646603 0.85 CYP2C9 (0.40) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL4863834 0.80 S1PR4 (0.47) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL6669991 0.76 GNRHR (0.48) S1PR4S1PR2S1PR3MAPTALDH1A1
SCHEMBL4858495 0.74 S1PR4 (0.49) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL6666790 0.73 GAA (0.72) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL6666402 0.73 S1PR4 (0.44) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL4860348 0.73 S1PR4 (0.47) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL4859926 0.73 S1PR4 (0.47) S1PR4S1PR2S1PR3GAAMAPT
SCHEMBL6670382 0.73 CYP2C9 (0.38) GAAMAPTALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed